- Home
- BIDU vs SLRX Comparison
BIDU vs SLRX Comparison
Compare BIDU & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIDU
- SLRX
- Stock Information
- Founded
- BIDU 2000
- SLRX N/A
- Country
- BIDU China
- SLRX United States
- Employees
- BIDU N/A
- SLRX N/A
- Industry
- BIDU Computer Software: Programming Data Processing
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- BIDU Technology
- SLRX Health Care
- Exchange
- BIDU Nasdaq
- SLRX Nasdaq
- Market Cap
- BIDU 28.5B
- SLRX 1.8M
- IPO Year
- BIDU 2005
- SLRX N/A
- Fundamental
- Price
- BIDU $85.82
- SLRX $0.64
- Analyst Decision
- BIDU Strong Buy
- SLRX
- Analyst Count
- BIDU 10
- SLRX 0
- Target Price
- BIDU $111.60
- SLRX N/A
- AVG Volume (30 Days)
- BIDU 2.2M
- SLRX 3.6M
- Earning Date
- BIDU 08-21-2025
- SLRX 08-08-2025
- Dividend Yield
- BIDU N/A
- SLRX N/A
- EPS Growth
- BIDU 34.31
- SLRX N/A
- EPS
- BIDU 10.01
- SLRX N/A
- Revenue
- BIDU $18,475,022,401.00
- SLRX N/A
- Revenue This Year
- BIDU $3.12
- SLRX N/A
- Revenue Next Year
- BIDU $5.62
- SLRX N/A
- P/E Ratio
- BIDU $8.68
- SLRX N/A
- Revenue Growth
- BIDU N/A
- SLRX N/A
- 52 Week Low
- BIDU $74.71
- SLRX $0.45
- 52 Week High
- BIDU $116.25
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- BIDU 50.28
- SLRX 41.73
- Support Level
- BIDU $84.82
- SLRX $0.66
- Resistance Level
- BIDU $91.25
- SLRX $0.90
- Average True Range (ATR)
- BIDU 1.40
- SLRX 0.12
- MACD
- BIDU 0.24
- SLRX -0.03
- Stochastic Oscillator
- BIDU 47.04
- SLRX 16.46
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.